반응식
[O:1]=[C:2]1[NH:7][N:6]=[C:5]([C:8]([OH:10])=[O:9])[CH:4]=[CH:3]1.[CH:11]1(I)[CH2:15][CH2:14][CH2:13][CH2:12]1.C(=O)([O-])[O-].[K+].[K+].C(Cl)Cl>CN(C=O)C>[CH:11]1([O:9][C:8]([C:5]2[CH:4]=[CH:3][C:2](=[O:1])[N:7]([CH:11]3[CH2:15][CH2:14][CH2:13][CH2:12]3)[N:6]=2)=[O:10])[CH2:15][CH2:14][CH2:13][CH2:12]1참가 물질
6
실험 절차
6-Oxo-1,6-dihydropyridazine-3-carboxylic acid (1 g, 7.14 mmol) was stirred with cyclopentyl iodide (2.05 ml, 17.8 mmol) and potassium carbonate (3 g, 21.4 mmol) in 15 ml DMF for 14 h at room temperature. 50 ml CH2Cl2 was added and the reaction mixture was filtered. The filtrate was concentrated and the title compound was purified by prep HPLC. Yield: 20 mg (0.072 mmol, 1%, MS m/z: 277(100%, M+1)).
후처리
- filtrationthe reaction mixture was filtered
- concentrationThe filtrate was concentrated
- customthe title compound was purified by prep HPLC
출처 및 근거
- ORD 기록
- ord-b0df505392df4751b6a9f468639da464
- 출처 데이터셋
- uspto-grants-2012_04
- 특허 번호
- US08163766B2
연결된 노트
불러오는 중…